| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
3
3
5
3
1
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
U.S. News evaluated 38 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 29.13 percent over the past year, 14.73 percent over the past three years, 11.74 percent over the past five years, and 14.82 percent over the past decade.
| Trailing Returns | Updated 04.30.2013 |
|---|---|
| Year to date | 20.0% |
| 1 Year | 29.1% |
| 3 Years (Annualized) | 14.7% |
| 5 Years (Annualized) | 11.7% |
| 10 Years (Annualized) | 14.8% |
Summary
The investment seeks to provide long-term growth of capital. The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified.
Fees
Fees are Low compared to funds in the same category.
BlackRock Health Sciences Opportunities Portfolio has an expense ratio of 2.07 percent.
Risk
Risk is Below Average compared to funds in the same category according to Morningstar.
